RADAR-CNS: Remote Assessment of Disease and Relapse – Central Nervous System

[4tux]

[url]http://www.radar-cns.org/[/url]

Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) is a new collaborative research programme that will explore the potential of wearable devices to help prevent and treat depression, multiple sclerosis and epilepsy.

RADAR-CNS is a major new research programme which is developing new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. RADAR-CNS aims to improve patients’ quality of life, and potentially to change how these and other chronic disorders are treated.

RADAR-CNS is jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and includes 23 organisations from across Europe and the US. It brings together experts from diverse fields including clinical research, engineering, computer science, information technology, data analytics and health services.